EPICS Therapeutics is a startup based in Belgium.
EPICS Therapeutics is a startup based in Belgium.
EPICS Therapeutics is a clinical-stage biotechnology company developing small-molecule modulators of RNA epigenetic targets. Its lead program, EP102, is a METTL3 inhibitor currently in clinical evaluation for solid tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.